F de Wolf

发表

Effect of human immunodeficiency virus (HIV) antibody knowledge on high-risk sexual behavior with steady and nonsteady sexual partners among homosexual men.

E M de Vroome, G J van Griensven, J. Goudsmit, 1989, American journal of epidemiology.

Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.

M. Sprangers, M. Chesney, F. de Wolf, 2001, Archives of internal medicine.

The effect of plasma drug concentrations on HIV‐1 clearance rate during quadruple drug therapy

J W Mulder, H. Schuitemaker, J. Beijnen, 1998, AIDS.

Rate of HIV‐1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen

A S Perelson, A. Perelson, J. Mittler, 1998, AIDS.

Longitudinal analysis of CD4 T cell counts, T cell reactivity, and human immunodeficiency virus type 1 RNA levels in persons remaining AIDS-free despite CD4 cell counts <200 for >5 years.

I P Keet, F Miedema, M R Klein, 1997, The Journal of infectious diseases.

Diagnostic value of specific IgM antibodies in primary HIV infection.

J. Parry, J. Goudsmit, F. de Wolf, 1988, AIDS.

AIDS prognosis based on HIV‐1 RNA, CD4+ T‐cell count and function: markers with reciprocal predictive value over time after seroconversion

I Spijkerman, C. Kuiken, F. de Wolf, 1997, AIDS.

Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy.

C H Fox, H. Schuitemaker, C. Fox, 1999, AIDS.

Alternative multidrug regimen provides improved suppression of HIV‐1 replication over triple therapy

H. Schuitemaker, G. Weverling, F. de Wolf, 1998, AIDS.